all report title image
  • Published On : Nov 2021
  • Code : CMI27
  • Industry : Medical Devices
  • Pages : 157
  • Formats :

Erectile dysfunction (impotence) is the inability to get and keep an erection firm enough for sexual intercourse. Erectile dysfunction symptoms might include persistent: trouble getting an erection, trouble keeping an erection, or reduced sexual desire.

Hormones are chemical messengers that influence cellular activity and impact every function of the body and chronic diseases such as heart disease, stroke, cancer, type 2 diabetes, obesity, arthritis, chronic kidney, liver disease, and chronic obstructive lung disease lead to erectile dysfunction as these diseases affect blood vessels, nerves, and hormone levels in the body. Erectile dysfunction (ED) is a common condition among male chronic kidney disease (CKD) patients. Its prevalence is estimated to be approximately 80% among these patients according to World Journal of Nephrology in 2014.

Global Erectile Dysfunction Devices Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 215.7 million cases and 4.49 million deaths due to coronavirus (COVID-19) were reported till August 29, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of Erectile Dysfunction Devices:

Researchers have been investigating the potential onset of erectile dysfunction in male patients of COVID-19. The researchers have stated three factors which can lead to the potential onset of erectile dysfunction (ED) in men who have suffered from COVID-19.

  • Vascular effects: COVID-19 can cause hyper inflammation throughout the body, especially in the heart and surrounding muscles. Blood supply to the penis can become blocked or narrowed as a result of a new or worsened vascular condition caused by the virus as vascular system and reproductive system are interconnected.
  • Psychological impact: Sexual activity is closely associated with mental health. The stress, anxiety, and depression caused by the virus and pandemic can be linked to sexual dysfunction and poor mood and may lead to erectile dysfunction.
  • Overall health deterioration: The COVID-19 causes a plethora of health issues. Men with low immunity and poor health are at greater risk of developing erectile dysfunction.

The global erectile dysfunction devices market is estimated to be valued at US$ 1,303.8 Mn in 2021, and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).

Figure 1: Global Erectile Dysfunction Devices Market Share (%) Analysis, By Device Type, 2021

Erectile Dysfunction Devices  | Coherent Market Insights

Increasing prevalence of erectile dysfunction due to chronic diseases and aging is the major factor that is expected to drive the market growth over the forecast period.

Increasing prevalence of erectile dysfunction due to various chronic diseases and aging of the global population, is expected to increase the growth of the global erectile dysfunction devices market over the forecast period. For instance, according to the article published by the Center for Disease Control and Prevention (CDC), in 2018, 51.8% of the U.S. adults had at least one chronic disease and 27.2% had multiple chronic diseases.

Furthermore, according to an article published in the Cleveland Clinic Center for Continuing Education in June 2018, around 17,781 new cases of erectile dysfunction are diagnosed in Massachusetts, U.S. every year, while approximately 617,715 new cases of erectile dysfunction are reported in the U.S. annually.

CMI table icon

Erectile Dysfunction Devices Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,303.8 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 9.5% 2028 Value Projection: US$ 2,467.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Device Type: Non-Surgical Devices (Vacuum Constriction Devices, Erectile Dysfunction Shockwave Generators, External Penile Rigidity Devices), Surgical Devices (    Vacuum Constriction Devices (Inflatable Implants, Malleable (Semi-Rigid) Implants), Other Surgical Devices))
  • By End User: Hospitals, Clinics, Ambulatory Surgery Centers
Companies covered:

Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed

Growth Drivers:
  • Increasing prevalence of erectile dysfunction due to chronic diseases and aging
  • Growing adoption of smoking and alcoholism
Restraints & Challenges:
  • Alternative treatment options

Growing Adoption of Smoking and Alcoholism   

For instance, according to the International Journal of Impotence Research: 2018, the use of tobacco has been considered as the major health problem worldwide, and the studies show that smoking causes erectile dysfunction among male population. Smoking can damage every part of the body and the chemicals present in cigarette smoke injure the lining of the blood vessels and can also affect the way they function. The chemicals present in the cigarette affects the blood vessels in the penis and, in turn, hampers erectile health. Even if the nervous system is operating at full strength, an erection may not be physically possible if the blood vessels are unhealthy due to smoking.

Furthermore, according to the JAMA Internal Medicine Journal: 2018, alcohol is regarded as a risk factor for erectile dysfunction (ED). Moreover, alcohol intake leads to increase in level of alcohol in blood. Alcohol being a depressant, can dampen the mood and decrease the sexual desire, which may cause difficultly for a person to achieve erections. For instance, according to the National Institute on Alcohol Abuse and Alcoholism: 2019, about 14.5 million people in the U.S., in the age group of 12 and older, have alcohol use disorder (AUD). This number includes 9.0 million men (6.8% of men in this age group) and 5.5 million women (3.9% of women in this age group).

Global Erectile Dysfunction Devices Market – Restraints

The presence of alternative medicines and herbal remedies for the treatment of erectile dysfunction is expected to hamper the growth of the global erectile dysfunction devices market over the forecast period. For instance, according to the Arab Journal of Urology: February 03, 2021, complementary and alternative medicines, including dietary supplements and herbal remedies, are increasingly used for the treatment of erectile dysfunction, particularly through over-the-counter and internet sources. Examples include herbal medicines (remedies) and dietary supplements, nutritional and lifestyle therapies, acupuncture and traditional Chinese medicine, body therapies (such as massage, cupping, and acupressure), homeopathy, mind–body techniques (such as meditation and yoga), energy medicine (such as reiki), and other traditional medicine disciplines such as Ayurveda, Unani, and Naturopathy.

Global Erectile Dysfunction Devices Market – Regional Analysis

On the basis of region, the global erectile dysfunction devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global erectile dysfunction devices market over the forecast period, owing to increasing number of launching new erectile dysfunction devices. For instance, in July 2019, Boston Scientific Corporation, a manufacturer of medical devices, launched the Tactra implant, which is a durable implant with a natural feel for treating erectile dysfunction.

Figure 2: Global Erectile Dysfunction Devices Market Value (US$ Mn), by Region, 2021

Erectile Dysfunction Devices  | Coherent Market Insights

Global Erectile Dysfunction Devices Market – Competitive Landscape

Major players operating in the global erectile dysfunction devices market include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed

Patients suffering from erectile dysfunction initially opt for non-surgical treatment options such as oral phosphodiesterase type-5 inhibitors (Viagra, Cialis, and others), injections, injections, suppositories, and penis pumps. However, if a patient fails to respond for all the above mentioned treatment then penile implant has found to be the most common option for men seeking treatment for erectile dysfunction. For instance, according to the Cleveland Clinic, a non-profit academic medical center based in Ohio, U.S., around 20,000 American men opt for a penis implant every year. Penile implants are becoming widely accepted treatment option in the U.S. which is anticipated to boost the market growth over the forecast period. Furthermore, according to the study published in the Translational Andrology and Urology in February 2020, around 85.9% of total 63,013 total penile implantation procedures were performed in the U.S. from 2005 to 2012.

Market Dynamics

The rising prevalence of erectile dysfunction mandates the need to launch various awareness campaigns to focus on the treatment of this condition. Several manufacturers such as Pfizer are focusing on launching campaigns regarding erectile dysfunction. Some noteworthy examples are European impotence awareness campaign and unbranded erectile dysfunction awareness campaign aiming at younger men. For instance, in the U.S., February 14 is considered as a National Impotence Day, where the government and healthcare workers create awareness about erectile dysfunction, its causes, and the available treatment options for erectile dysfunction. Moreover, they also focus on the types of erectile dysfunction and how it affects the mental health.

Furthermore, several market players commercialize various technologically advanced non-invasive devices for the treatment of erectile dysfunction, which is expected to boost the market growth over the forecast period. For instance, Vertica is a non-invasive home use medical device designed to enhance erectile quality, which is manufactured by OHH-MED Medical Ltd., a medical device company.

Key features of the study:

  • This report provides an in-depth analysis of global erectile dysfunction devices market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global erectile dysfunction devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global erectile dysfunction devices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global erectile dysfunction devices market

Detailed Segmentation:

  • Global Erectile Dysfunction Devices Market, By Device Type:
    • Non-Surgical Devices
      • Vacuum Constriction Devices
      • Erectile Dysfunction Shockwave Generators
      • External Penile Rigidity Devices
    • Surgical Devices
      • Vacuum Constriction Devices
        • Inflatable Implants
        • Malleable (Semi-Rigid) Implants
      • Other Surgical Devices
  • Global Erectile Dysfunction Devices Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
  • Global Erectile Dysfunction Devices Market, By Region:
    • North America
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country:
          • U.S.
          • Canada
    • Latin America
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country:
          • Brazil
          • Mexico
          • Argentina
          • Rest of Latin America
    • Europe
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country:
          • U.K.
          • Germany
          • Italy
          • Spain
          • France
          • Russia
          • Rest of Europe
    • Asia Pacific
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country
          • China
          • India
          • Japan
          • Australia
          • South Korea
          • ASEAN
          • Rest of Asia Pacific
    • Middle East
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country:
          • GCC
          • Israel
          • Rest of Middle East
    • Africa
      • By Device Type:
        • Non-Surgical Devices
          • Vacuum Constriction Devices
          • Erectile Dysfunction Shockwave Generators
          • External Penile Rigidity Devices
        • Surgical Devices
          • Penile Implants
            • Inflatable Implants
            • Malleable (Semi-Rigid) Implants
          • Other Surgical Devices
        • By End User:
          • Hospitals
          • Clinics
          • Ambulatory Surgery Centers
        • By Country/Region:
          • South Africa
          • Central Africa
          • North Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Coloplast Corp.
    • Zephyr Surgical Implants
    • Owen Mumford Ltd.
    • Augusta Medical Systems
    • Storz medical AG
    • Promedon
    • The Elator
    • Timm Medical
    • Silimed

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global erectile dysfunction devices market is expected to exhibit a CAGR of 9.5% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 1,303.8 Mn in 2021.
Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed are some of the prominent players operating in the market.
The market is expected to be valued at US$ 2,467.5 Mn in 2028.
North America is the prominent region in the market.
Increasing prevalence of erectile dysfunction due to chronic diseases and aging, and growing adoption of smoking and alcoholism are some of the driving factors, which are expected to drive growth of the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo